Inventor

LI SHAOLING

US7 patents

⚠️ This page may combine multiple inventors who share the name “LI SHAOLING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE BIOPHARMA R&D IP LLC

3 patents

US10369142B2Aug 6, 2019

REVOLUTION MEDICINES INC

2 patents

US11220501B2Jan 11, 2022

Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor

REVOLUTION MEDICINES INC3 citations68

US12528807B2Jan 20, 2026

Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor

REVOLUTION MEDICINES INC0 citations57

ALZA CORP

1 patent

US7338663B2Mar 4, 2008

Expandable osmotic composition and coating suspension

ALZA CORP4 citations61

HU YIQIAO

1 patent

US9066870B2Jun 30, 2015

Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles

HU YIQIAO3 citations47

LI SHAOLING

THERAVANCE BIOPHARMA R&D IP LLC

Combination dosage form of a mu opioid receptor antagonist and an opioid agent

Combination dosage form of a mu opioid receptor antagonist and an opioid agent

Combination dosage form of a mu opioid receptor antagonist and an opioid agent

REVOLUTION MEDICINES INC

Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor

Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor

ALZA CORP

Expandable osmotic composition and coating suspension

HU YIQIAO

Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles